LivaNova PLC

For the period ended Mar 31, 2024. Filed May 3, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 3, 2024

LIVN$91.14-1.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)

	March 31, 2024	December 31, 2023
ASSETS
Current Assets:
Cash and cash equivalents	$309,191	$266,504
Restricted cash	306,492	311,368
Accounts receivable, net of allowance of $11,026 at March 31, 2024 and $12,019 at December 31, 2023	209,431	215,072
Inventories	153,176	147,887
Prepaid and refundable taxes	22,543	20,145
Prepaid expenses and other current assets	39,184	27,182
Total Current Assets	1,040,017	988,158
Property, plant and equipment, net	152,237	154,181
Goodwill	771,817	782,941
Intangible assets, net	253,927	261,178
Operating lease assets	50,260	50,845
Investments	22,675	22,843
Deferred tax assets	113,687	118,858
Long-term derivative assets	41,617	38,496
Other assets	13,365	12,063
Total Assets	$2,459,602	$2,429,563
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
Current debt obligations	$19,704	$18,111
Accounts payable	75,944	80,845
Accrued liabilities and other	94,029	107,301
Current litigation provision liability	16,980	10,756
Taxes payable	29,761	23,340
Accrued employee compensation and related benefits	91,353	94,630
Total Current Liabilities	327,771	334,983
Long-term debt obligations	604,753	568,543
Contingent consideration	80,769	80,902
Deferred tax liabilities	10,974	11,567
Long-term operating lease liabilities	43,724	45,388
Long-term employee compensation and related benefits	17,062	17,254
Long-term derivative liabilities	104,920	45,569
Other long-term liabilities	48,092	47,729
Total Liabilities	1,238,065	1,151,935
Commitments and contingencies (Note 6)
Stockholders’ Equity:
Ordinary Shares, £1.00 par value: unlimited shares authorized; 54,295,837 shares issued and 54,148,808 shares outstanding at March 31, 2024; 53,942,151 shares issued and 53,918,222 shares outstanding at December 31, 2023	82,975	82,533
Additional paid-in capital	2,192,676	2,189,517
Accumulated other comprehensive loss	(45,206)	(27,883)
Accumulated deficit	(1,008,427)	(966,484)
Treasury stock at cost, 147,029 ordinary shares at March 31, 2024; 23,929 ordinary shares at December 31, 2023	(481)	(55)
Total Stockholders’ Equity	1,221,537	1,277,628
Total Liabilities and Stockholders’ Equity	$2,459,602	$2,429,563

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.